International Journal of Pharmaceutical Investigation
Volume 16, Issue 4
2026 · pp. 1202–1724 · 50 articles
- Volume
- 16
- Issue
- 4
- Published
- 2026
- Pages
- 1202–1724
- Articles
- 50
- Sections
- 2
- ISSN
- Print - 2230-973X, Online -2230-9713
- Journal
- IJPI
In this issue
41–50 of 50Original Article(continued)
- Article
Magesh Mohan, Renukadevi Jeyavelkumaran, Sanjay Valliappan, Shakthi Harikrishnan, Kadir Aravindan, Balaji Ravikuma
pp. 1601–1621 · DOI: 10.5530/ijpi.20260291 · 2026
Background Breast cancer progression is governed by highly interconnected signaling networks involving receptor tyrosine kinases and hormone-responsive nuclear receptors, which collectively drive tumor heterogeneity, ada…
- Article
Md. Zeyaullah, Kamal Ahmad
pp. 1622–1628 · DOI: 10.5530/ijpi.20260014 · 2026
Background This study evaluates COVID-19 vaccination coverage, vaccine effectiveness against SARS-CoV-2 variants, and associated health consequences in the five most important Indian metropolitan cities: Delhi, Mumbai, B…
- Article
Krutika Lolsure, Vijay Kumbar, Priya Shetti, Mitali Kubade, Malleswara Peram
pp. 1629–1634 · DOI: 10.5530/ijpi.20260016 · 2026
Introduction Glioblastoma multiforme, an extremely aggressive form of brain cancer, presents significant challenges in treatment, despite the application of surgical intervention, radiation therapy, and chemotherapy. Res…
- Article
Sruthi Sai Kaveripakam, Sreedevi Adikay, Sowmya Venkata Donthamsetty, Surekha Lakshmi Khandavilli
pp. 1635–1641 · DOI: 10.5530/ijpi.20260025 · 2026
Background Phytochemicals exhibit diverse therapeutic properties with minimal adverse effects and documented their benefits against metabolic disorders. Inhibition of pancreatic lipase is a validated strategy for managin…
- Article
Tahani Bakhsh
pp. 1642–1656 · DOI: 10.5530/ijpi.20260058 · 2026
Background MDM2 is an E3 ubiquitin ligase that suppresses p53, promotes its degradation, inhibits apoptosis, and drives uncontrolled cancer cell growth. Targeting the MDM2-p53 interaction is therefore a promising strateg…
- Article
K. K Mueen Ahmed, M Chaman Sab, Mohammed Yunus, Shery Jacob, Jigar N. Shah, Hiral J. Shah, Mahesh Attimarad, Sreeharsha Nagaraja, Rashed M. Almuqbil, Bandar E. Al-Dhubiab, Katharigatta N. Venugopala, Abdullah M. Alotaibi, Ahmed S. Alnaim
pp. 1657–1665 · DOI: 10.5530/ijpi.20260004 · 2026
Objective Drug delivery and pharmaceutical-analysis research spans a wide range of sub-disciplines - nanocarrier formulation, transdermal and iontophoretic delivery, analytical method development, and computational drug …
- Article
Jahanvi Patel, Tejal Mehta
pp. 1666–1679 · DOI: 10.5530/ijpi.20260292 · 2026
Background The primary objective of this study was to develop, optimize and evaluate a paediatric-friendly, pullulan-based Mouth Dissolving Film (MDF) of Ferrous Bisglycinate as a novel iron delivery system. The work aim…
- Article
S. Revathy, K. Shoba, A. Vidhya
pp. 1680–1695 · DOI: 10.5530/ijpi.20260024 · 2026
Background Trigonella foenum-graecum (fenugreek) is a widely utilized medicinal herb known for its therapeutic potential in managing metabolic disorders. This study aimed to extract and characterise the bioactive constit…
- Article
Sanket Keshav Tambe, Rohit Jaysing Bhor, Sagar Dattatray Magar, Mayur Shivaji Bhosale, Shubham Popatrao Mankar, Datta Macchindra Abhale, Sachin Tukaram chavan, Gaurav Subhash Damre
pp. 1696–1718 · DOI: 10.5530/ijpi.20260011 · 2026
Background: This study focuses on the computational (in silico) analysis of 1H-phenothiazine derivatives to estimate their pharmacological potential, particularly as inhibitors of monoamine oxidase (PDB ID: 2BXR), an enz…
- Article
Vishal Kulkarni, Kavya Mattikatti, Manasa Desai, Darshan Randewadi, Nida Sirdesai, Sanatkumar Bharamu Nyamagoud, AHM Viswanatha Swamy
pp. 1719–1724 · DOI: 10.5530/ijpi.20260176 · 2026
Aim: To evaluate early changes in symptom-specific Health-Related Quality of Life (HRQoL) among Esophageal cancer patients receiving chemotherapy up to the second cycle and to assess demographic and treatment-related dif…

